Swissmedic has finalized a redundancy scheme in response to an announced staff reduction at the organization.…
Category: Europe
europe updates on medical device regulation and quality.
Swissmedic Expands Approval for Calquence® Therapeutic Indication
On January 15, 2026, Swissmedic officially approved an extension of the therapeutic indication for Calquence®, marking…
Temporary Authorization for Abilify i.m. Injection Solution Due to Supply Shortage
Swissmedic, Switzerland’s authority for therapeutic products, has announced the temporary authorization for the distribution of Abilify…
Swissmedic Confirms New Blood Donation Guidelines to Address vCJD Concerns
On February 1, 2026, new blood donation criteria from Swiss Transfusion SRC will take effect, marking…
Swissmedic welcomes Vincenza Trivigno as new Executive Director
On January 12, 2026, Swissmedic, the Swiss agency responsible for the authorization and monitoring of therapeutic…
Streamline Medical Device Registration with Swissmedic: Free Webinar Highlights swissdamed Tools
Swissmedic, Switzerland’s national agency for therapeutic products, is offering a complimentary webinar on May 28, 2026.…
December 2025 MHRA Safety Updates: New Guidance for Medicine and Medical Device Users
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued its December 2025 roundup of the…
Critical Updates: Field Safety Notices from December 22–26, 2025
The latest Field Safety Notices (FSNs) issued between December 22 and December 26, 2025, are now…
Critical Updates: Field Safety Notices Published Between 29 December 2025 and 2 January 2026
The UK Health Authorities have released an updated list of Field Safety Notices (FSNs) covering the…
Regulatory Update: Swissmedic Expands Therapeutic Indication for Jaypirca®
Swissmedic has announced an extension of the therapeutic indication for Jaypirca®, a development that could impact…